Why CureVac (CVAC) Shares Are Volatile

CureVac BV CVAC shares have been volatile over the past week, gaining some 25% to $4.23, amid increased trading volume following the U.S.’s first human death from H5N1 bird flu.

What To Know: While the CDC maintains that the public risk remains low, the outbreak has already devastated poultry farms across 16 states. The news has driven interest in vaccine developers, including CureVac, which is collaborating with GSK plc GSK to test updated mRNA-based bird flu vaccine candidates.

With $72 million recently allocated by the U.S. government for bird flu vaccine production and competitors like Moderna securing substantial funding, investors speculate that CureVac could gain from similar opportunities. The company's mRNA technology could provide a next-generation solution, though its current vaccines target earlier strains.

CureVac's relatively smaller market cap could also make it more sensitive to speculative activity, and any developments in bird flu preparedness could impact its share price significantly.

Read Also: US Stocks To Open On A Tentative Note As Traders Remain Cautious Ahead Of Friday’s Crucial Jobs Data

How To Buy CVAC Stock

By now you're likely curious about how to participate in the market for CureVac – be it to purchase shares, or even attempt to bet against the company.

Buying shares is typically done through a brokerage account. You can find a list of possible trading platforms here. Many will allow you to buy ‘fractional shares,' which allows you to own portions of stock without buying an entire share. For example, some stock, like Berkshire Hathaway, can cost thousands of dollars to own just one share. However, if you only want to invest a fraction of that, brokerages will allow you to do so.

If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform, or a broker who will allow you to ‘go short' a share of stock by lending you the shares to sell. The process of shorting a stock can be found at this resource. Otherwise, if your broker allows you to trade options, you can either buy a put option, or sell a call option at a strike price above where shares are currently trading – either way it allows you to profit off of the share price decline.

According to data from Benzinga Pro, CVAC has a 52-week high of $5.28 and a 52-week low of $2.22.

Image courtesy of CureVac